abstract |
This invention relates to compounds of formula (I) wherein R1 is selected from the group consisting of (A), (B), (C), (D), (E) (F) pharmaceutically acceptable salts thereof, and to compositions that are p38 MAPK inhibitors, useful as anti-inflammatory agents in the treatment of, inter alia, diseases of the respiratory tract. |